Matthew W. Davis

Chief Development Officer, Aquestive Therapeutics, Inc.

Companies

Aquestive Therapeutics, Inc.Chief Development Officer Nov 12, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aquestive Therapeutics, Inc. AQST100,000 shares²$375.5K at $3.75Mar 9, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 9, 2026Granted 50,000 shares of Aquestive Therapeutics, Inc.²
Nov 10, 2025Granted 50,000 shares of Aquestive Therapeutics, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAquestive Therapeutics, Inc., Chief Development Officer
2
SEC EDGARAquestive Therapeutics, Inc. shares after the filing of Mar 9, 2026
3
SEC EDGARForm 4 filed Nov 12, 2025